HESI RN 301 Pharmacology Final Exam | Nurselytic

Questions 51

HESI RN

Home > HESI RN > HESI Pharmacology > HESI RN 301 Pharmacology Final Exam
HESI RN Test Bank

HESI RN 301 Pharmacology Final Exam Questions

Extract:


Question 1 of 5

A client with chronic kidney disease (CKD) is receiving calcium acetate 667 mg PO. A decrease in which blood value indicates to the nurse that the medication is having the desired effect?

Correct Answer: A

Rationale: Calcium acetate binds dietary phosphate in the gut, reducing serum phosphate levels in CKD patients with hyperphosphatemia, indicating effectiveness. It doesn’t directly affect pH, calcium, or potassium levels.

Question 2 of 5

Correct Answer:

Rationale:

Question 3 of 5

Correct Answer:

Rationale:

Question 4 of 5

Correct Answer:

Rationale:

Question 5 of 5

Correct Answer:

Rationale:

Similar Questions

Which instruction should the nurse provide an unlicensed assistive personnel (UAP) who is assisting with the personal care of a client receiving clopidogrel?
A patient with heart failure (HF) develops hyperaldosteronism and spironolactone is prescribed. Which instruction should the nurse include in the patient's plan of care?
A client who is a vegetarian has a new prescription for warfarin. The client reports eating leafy green vegetables every day. How should the nurse respond?
An increase in which serum lab value indicates to the nurse that a prescription for atorvastatin is having the desired effect for a client at risk for coronary artery disease?
A client diagnosed with chronic obstructive pulmonary disease (COPD) is given a new prescription for tiotropium via an inhalation device. Which statement indicates that the client understands the instructions for using this medication?

Access More Questions!

HESI RN Basic

$89/ 30 days

 

HESI RN Premium

$150/ 90 days